<SEC-DOCUMENT>0001213900-25-105603-index.html : 20251104 <SEC-HEADER>0001213900-25-105603.hdr.sgml : 20251104 <ACCEPTANCE-DATETIME>20251104071351 ACCESSION NUMBER: 0001213900-25-105603 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20251104 FILED AS OF DATE: 20251104 DATE AS OF CHANGE: 20251104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LakeShore Biopharma Co., Ltd. CENTRAL INDEX KEY: 0001946399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41598 FILM NUMBER: 251446434 BUSINESS ADDRESS: STREET 1: BUILDING NO. 2, 38 YONGDA ROAD STREET 2: DAXING BIOMEDICAL INDUSTRY PARK CITY: DAXING DISTRICT, BEIJING STATE: F4 ZIP: 102629 BUSINESS PHONE: 17327133678 MAIL ADDRESS: STREET 1: BUILDING NO. 2, 38 YONGDA ROAD STREET 2: DAXING BIOMEDICAL INDUSTRY PARK CITY: DAXING DISTRICT, BEIJING STATE: F4 ZIP: 102629 FORMER COMPANY: FORMER CONFORMED NAME: YS Biopharma Co., Ltd. DATE OF NAME CHANGE: 20230310 FORMER COMPANY: FORMER CONFORMED NAME: YishengBio Co., Ltd DATE OF NAME CHANGE: 20220912 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0263592-6k_lakeshore.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0263592-6k_lakeshore.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea026359201ex99-1_lakeshore.htm <DESCRIPTION>PRESS RELEASE - LAKESHORE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT FOR GOING-PRIVATE TRANSACTION <TEXT> Document 2 - file: ea026359201ex99-1_lakeshore.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea026359201ex99-2_lakeshore.htm <DESCRIPTION>AGREEMENT AND PLAN OF MERGER, DATED NOVEMBER 4, 2025, BY AND AMONG LAKESHORE BIOPHARMA CO., LTD, OCEANPINE SKYLINE INC. AND OCEANPINE MERGER SUB INC <TEXT> Document 3 - file: ea026359201ex99-2_lakeshore.htm
</DOCUMENT> </SEC-DOCUMENT>